熊远珍 胡海荣 陈芬儿 Jan Balzarini Christophe Pannecouque Erik De Clercq. 非核苷类逆转录酶抑制剂的研究XVⅢ: 4-烯丙基和4-叠氮基取代的三嗪类化合物的合成及抗HIV活性J. 药学学报, 2009,44(2): 145-149.
引用本文: 熊远珍 胡海荣 陈芬儿 Jan Balzarini Christophe Pannecouque Erik De Clercq. 非核苷类逆转录酶抑制剂的研究XVⅢ: 4-烯丙基和4-叠氮基取代的三嗪类化合物的合成及抗HIV活性J. 药学学报, 2009,44(2): 145-149.
XIONG Yuan-Zhen, Hu-Hai-Rong, Chen-Fen-Er, Jan Balzarini, Christophe Pannecouque, Erik De Clercq. Non-nucleoside reverse transcriptase inhibitors (Part 18): Synthesis and anti-HIV activity of 4-allylamino or 4-azido substituted diaryltriazinesJ. 药学学报, 2009,44(2): 145-149.
Citation: XIONG Yuan-Zhen, Hu-Hai-Rong, Chen-Fen-Er, Jan Balzarini, Christophe Pannecouque, Erik De Clercq. Non-nucleoside reverse transcriptase inhibitors (Part 18): Synthesis and anti-HIV activity of 4-allylamino or 4-azido substituted diaryltriazinesJ. 药学学报, 2009,44(2): 145-149.

非核苷类逆转录酶抑制剂的研究XVⅢ: 4-烯丙基和4-叠氮基取代的三嗪类化合物的合成及抗HIV活性

Non-nucleoside reverse transcriptase inhibitors (Part 18): Synthesis and anti-HIV activity of 4-allylamino or 4-azido substituted diaryltriazines

  • 摘要:

    在已有工作基础上, 基于分子对接设计合成了8个新的4-烯丙基取代和4-叠氮基取代的二芳基三嗪类衍生物。抗HIV-1活性的测试结果表明所有新化合物均具有抗HIV-1活性。其中化合物7c不仅抑制HIV-1野生株的复制 (IC50 = 0.034 μmol×L-1, SI = 6 475), 且对Y181CK103C双突变酶显示出较强的抑制活性, IC50值为9.39 μmol×L-1, 高于奈韦拉平。

     

    Abstract:

    Eight new diaryltriazine derivatives containing 4-allylamino and 4-azido substitutes guided by molecular docking have been designed and synthesized based on our previous work.  The evaluation of HIV  inhibitory activity demonstrated that all compounds were potent against HIV-1 replication.  The most active compound 7c exhibited activity against HIV-1 (IC50 = 0.034 μmol×L-1, SI = 6 475) and the double mutant strain (IC50 = 9.39 μmol×L-1) in the micromolar range, which was more potent than nevirapine.

     

/

返回文章
返回